Expanding Indications: Beyond Obesity and Diabetes The GLP-1 drug pipeline in 2026 reaches well beyond weight management and glycaemic control
People should not rely on weight loss patches to lose weight
Monoamine oxidases (MAO-A and MAO-B) are mitochondrial enzymes involved in neurotransmitter catabolism, generating hydrogen peroxide and aldehydes as ancillary by-products
For instance, youll have to eat more than 100 grams of oranges each day to meet your daily needs
While semaglutide provides substantial metabolic benefits, its GI AEs, most notably nausea, vomiting, diarrhoea, and constipation, can compromise treatment adherence, particularly during the early dose-escalation phase
Regular review of treatment is necessary for all patients with type 2 diabetes to optimise individual goals and ensure medicine regimens remain appropriate